- Country: Czech Republic
- Summary: Drug Supply-Pliia 2025-Repeated Management
- CZT Ref No: 123313202
- Deadline: 28 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 25551000
- Notice Type: Tender
- Document Ref. No.: 486815-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of performance is continuous deliveries according to Annex 1 Purchase contracts - price offer, to the extent and in accordance with the tender conditions are supplies of the medicinal product Denosumab - M05BX04.
Drug supply-PLIIA 2025-Repeated Management
DOC TITLE: DELIVERY DELIVERY-PLIIA 2025-Repeated proceedings
Contract Type: supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDrug Supply-Pliia 2025-Repeated Management - Czech Tender
The RHEUMATIC INSTITUTE, a Government sector organization in Czech Republic, has announced a new tender for Drug Supply-Pliia 2025-Repeated Management. This tender is published on CzechTenders under CZT Ref No: 123313202 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-28.
The estimated tender value is CZK 25551000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
